Mueller et al.29 reported that combined treatment using Hedgehog inhibitors (cyclopamine/CUR199691) and the mTOR inhibitor rapamycin in addition to gemcitabine effectively eliminated tumorigenic CSCs in human pancreatic cancer. The gene discussed is MTOR; the disease is familial pancreatic carcinoma.